Viewing Study NCT00148395


Ignite Creation Date: 2025-12-24 @ 1:18 PM
Ignite Modification Date: 2026-01-03 @ 10:22 PM
Study NCT ID: NCT00148395
Status: COMPLETED
Last Update Posted: 2008-04-22
First Post: 2005-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.
Sponsor: Aktion Bronchialkarzinom e.V.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module